Or Refractory Melanoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2025-05-29
Clinical Trial Update: RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVER [Phase 1]
The DISCOVER Phase 1 trial evaluating RTA 408 in advanced solid tumors, including metastatic non-small cell lung cancer and relapsed/refract…